Loading clinical trials...
Loading clinical trials...
ACT: Analyzing the Composition of Tears to Identify Cancer (Breast, Ovarian, Colon)
This study will further evaluate the use of protein identification or protein pattern (signature) found in tears. We hypothesize that differences exist between the protein profile in tear fluid from patients with versus without cancer.
Specifically, this study will compare the protein profile in tear fluid from patients with breast, ovarian or colon cancer versus "normal male and female patients" for differences that show promise as a diagnostic indicator. If such differences can be found, then their diagnostic potential will be assessed and developed further in a subsequent study. The long-term goal of this project will be to develop a screening tool for the detection of breast and/or other cancers.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University of Arkansas For Medical Sciences
Little Rock, Arkansas, United States
Start Date
December 1, 2006
Primary Completion Date
February 1, 2016
Completion Date
February 1, 2016
Last Updated
August 5, 2021
150
ACTUAL participants
Tear collection
OTHER
Lead Sponsor
University of Arkansas
Collaborators
NCT04550494
NCT05039801
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions